S.No. | Products | % |
| | IR PELLETS | |
1 | Aprepitant | 40% w/w |
2 | Atorvastatin | 7.5% / 10% / 20% w/w |
3 | Clopidogrel | 40% / 50% w/w |
4 | Dabigatran | 40% w/w |
5 | Dutasteride | 0.5% w/w |
6 | Fenofibrate | 66.23% w/w |
7 | Itraconazole | 20% / 22% / 27.5% / 30% / 32.25% / 32.5% / 40% /44% w/w |
8 | Mebeverine Hcl | 40% w/w |
9 | Orlistat | 50% w/w |
10 | Pregabalin | 25% / 50% / 75% w/w |
11 | Rosuvastatin | 7.5% / 10% w/w |
12 | Sertraline | 25% w/w |
13 | Telmisartan | 20% w/w |
| | SR PELLETS | |
1 | Diclofenac Sodium | 33% / 35% / 40% w/w |
2 | Diltiazem Hcl | 54% w/w |
3 | Domperidone | 17% / 20% / 22% / 30% / 40% w/w |
4 | Flurbiprofen | 60% w/w |
5 | Galantamine | 8% w/w |
6 | Indomethacin | 27.5% w/w |
7 | Ketoprofen | 60% / 70% w/w |
8 | Levosulpiride | 50% w/w |
9 | Mebeverine Hcl | 60% / 80% w/w |
10 | Mesalamine | 80% w/w |
11 | Metoprolol Succinate | 65% w/w |
12 | Nicardipine Hcl | 20% w/w |
13 | Nitroglycerin | 1.13% / 1.4% / 2.5% w/w |
14 | Propranolol | 47% w/w |
15 | Tamsulosin SR | 0.4 mg + Dutasteride IR 0.5 mg |
16 | Tamsulosin Hcl | 0.12% / 0.13% / 0.14% / 0.16% / 0.20% / 0.32% w/w |
17 | Theophylline | 75% w/w |
18 | Tolterodine Tartrate | 2.1% w/w |
19 | Venlafaxine Hcl | 30% / 33% / 35% / 50% w/w |
| | EC PELLETS | |
1 | Aspirin | 40% w/w |
2 | Dexlansoprazole | 17% / 20% / 22.5% / 23% w/w |
3 | Duloxetine Hel | 9% / 12% / 17% / 19% / 20% / 25% w/w |
4 | Esomeprazole | 15% / 21.5% /22.5% / 26.67% / 27.5% w/w |
5 | Lansoprazole | 8.5% / 10% / 12% w/w |
6 | Omeprazole | 8.5% / 10% / 20% / 23.5% 4/w |
7 | Pantoprazole Sodium | 16% / 20% / 22.5% / 25% w/w |
8 | Rabeprazole | 7.5% / 8.5% / 15% / 22.5% / 23.5% w/w |
| | MUPS | |
1 | Esomeprazole Magnesium DR | 11% / 15% / 22.5% w/w |
2 | Lansoprazole DR | 12.5% w/w |
3 | Omeprazole DR | 10% / 20% w/w |
4 | Omeprazole Magnesium DR | 8.5% / 20% w/w |
5 | Rabeprazole DR | 10% / 15% w/w |
| | TASTE MASKED GRANULES | |
1 | Azithromycin | 7.5% / 159 w/w |
2 | Ciprofloxacin | 20% / 40% w/w |
3 | Clarithromycin | 27.5% / 30% / 33% / 42% w/W |
| |
| |
| | |
